Evaluation of the immunogenicity and safety of a new formulation of omalizumab (solution for injection) in patients with allergic (IgE-mediated) asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
The effects of anti-IL-13 on allergen-induced responses; a Phase II study in subjects with mild atopic asthma - The allergen challenge as a model of allergic asthma for proof-of-concept studies Source: Annual Congress 2008 - Clinical trial - The effects of an anti-IL-13 human monoclonal antibody, IMA-638, on allergen-induced airway responses in subjects with mild atopic asthma Year: 2008
The influence of the allergen-specific immunotherapy (ASIT) against the backdrop of an immunomodulator in patients suffering from seasonal allergic rhinitis (SAR) on the level of cytokines, IgE and IgG. Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020
DNA vaccine encoding both PD-L1 and Der p 2 was more effective than DNA vaccine encoding only Der p 2 in suppressing airway inflammation in a murine model of allergic airway disease Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007
DNA vaccine encoding both FasL and Der p 2 was more effective than DNA vaccine encoding only Der p 2 in suppressing airway inflammation in a mouse model of asthma Source: Eur Respir J 2006; 28: Suppl. 50, 224s Year: 2006
Efficiency of a DNA vaccine on allergic asthma Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012
Omalizumab (Xolair®) reduces exacerbations in adolescents more than in adults with allergic (IgE-mediated) asthma: a subgroup analysis of pooled clinical trials Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008
Efficacy and safety of the short term immunotherapy (SIT) in allergic rhinoconjunctivitis (AR) Source: Eur Respir J 2005; 26: Suppl. 49, 134s Year: 2005
A randomized double-blind study of specific immunotherapy (SIT) in patients with seasonal allergic rhinitis: effects on clinical and inflammatory markers Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001
Evaluation and efficacy of allergen immunotherapy in asthma Source: Eur Respir J 2005; 26: Suppl. 49, 399s Year: 2005
Relation between circulating allergen specific IgE, skin prick test reactivity and wheeze. Results from phase two of the international study of asthma and allergy in childhood (ISAAC) Source: Annual Congress 2008 - Asthma epidemiology Year: 2008
Allergen specific immunotherapy efficacy in children with pollen-food allergy syndrome and different IgE profiles to recombinant component-resolved allergens. Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017
Dermatophagoïdes Farinae 1 (Der f1) vaccine in a mice model of allergic asthma Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013
Novel intradermal influenza vaccine: phase 3 data in targeted adult populations Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care Year: 2008
Allergen immunotherapy: therapeutic vaccines for allergic diseases Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=409 Year: 2003
Sublingual allergen specific immunotherapy in children with respiratory allergies – long lasting efficacy Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017
Co-administration of vaccination with DNA encoding T cell epitope on the Der p and BCG inhibited allergic responses in mice Source: Eur Respir J 2003; 22: Suppl. 45, 483s Year: 2003
Antibody response after varicella vaccination similar in children treated with budesonide inhalation suspension (BIS) or nonsteroidal conventional asthma therapy (NSCAT) Source: Eur Respir J 2006; 28: Suppl. 50, 711s Year: 2006
Effect of nasal polivalent bacterial lysate on the clinical course of seasonal allergic rhinitis in children - preliminary study. Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020